JPS6147840B2 - - Google Patents
Info
- Publication number
- JPS6147840B2 JPS6147840B2 JP12235779A JP12235779A JPS6147840B2 JP S6147840 B2 JPS6147840 B2 JP S6147840B2 JP 12235779 A JP12235779 A JP 12235779A JP 12235779 A JP12235779 A JP 12235779A JP S6147840 B2 JPS6147840 B2 JP S6147840B2
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- gold
- methylpropanoyl
- sodium
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004201 L-cysteine Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- VUAFHZCUKUDDBC-BYPYZUCNSA-N Bucillamine Chemical compound CC(C)(S)C(=O)N[C@@H](CS)C(O)=O VUAFHZCUKUDDBC-BYPYZUCNSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002344 gold compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- DTNJZLDXJJGKCM-UHFFFAOYSA-K sodium;trichlorogold Chemical compound [Na].Cl[Au](Cl)Cl DTNJZLDXJJGKCM-UHFFFAOYSA-K 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000013878 L-cysteine Nutrition 0.000 description 1
- CHZXKDFOXLOZMI-UHFFFAOYSA-N S-(1-chloro-2-methyl-1-oxopropan-2-yl) benzenecarbothioate Chemical compound C(C1=CC=CC=C1)(=O)SC(C(=O)Cl)(C)C CHZXKDFOXLOZMI-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- -1 ferrous gold halide Chemical class 0.000 description 1
- IZLAVFWQHMDDGK-UHFFFAOYSA-N gold(1+);cyanide Chemical compound [Au+].N#[C-] IZLAVFWQHMDDGK-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- VMDSWYDTKFSTQH-UHFFFAOYSA-N sodium;gold(1+);dicyanide Chemical compound [Na+].[Au+].N#[C-].N#[C-] VMDSWYDTKFSTQH-UHFFFAOYSA-N 0.000 description 1
- AGHLUVOCTHWMJV-UHFFFAOYSA-J sodium;gold(3+);2-sulfanylbutanedioate Chemical compound [Na+].[Au+3].[O-]C(=O)CC(S)C([O-])=O.[O-]C(=O)CC(S)C([O-])=O AGHLUVOCTHWMJV-UHFFFAOYSA-J 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12235779A JPS5645487A (en) | 1979-09-22 | 1979-09-22 | Antirheumatic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12235779A JPS5645487A (en) | 1979-09-22 | 1979-09-22 | Antirheumatic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5645487A JPS5645487A (en) | 1981-04-25 |
| JPS6147840B2 true JPS6147840B2 (enrdf_load_stackoverflow) | 1986-10-21 |
Family
ID=14833894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12235779A Granted JPS5645487A (en) | 1979-09-22 | 1979-09-22 | Antirheumatic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5645487A (enrdf_load_stackoverflow) |
-
1979
- 1979-09-22 JP JP12235779A patent/JPS5645487A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5645487A (en) | 1981-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB866184A (en) | Tri-iodo-benzoic acid derivatives | |
| JP3182464B2 (ja) | １−シアノメチル−４−カルボキシメチル−２−ケトピペラジン、それの塩類、およびそれらの製造 | |
| GB767788A (en) | Polyiodinated phenyl fatty acid compounds and process for their manufacture | |
| JPH0462319B2 (enrdf_load_stackoverflow) | ||
| JPS6147840B2 (enrdf_load_stackoverflow) | ||
| JPH08119932A (ja) | Ｓ−ヒドロキシプロピル−ｌ−システインの製造法 | |
| JPH0761993B2 (ja) | アジドスルホニル安息香酸の製造法 | |
| KR870001570B1 (ko) | 피롤리딘 유도체의 제조방법 | |
| Savard et al. | SYNTHESIS OF A NEW α-AMINO ACID, S-METHYL-β, β-DIMETHYLCYSTEINE | |
| EP0040418B1 (en) | Process for preparing an 1h-indazol-3-ylacetic acid derivative | |
| JPS61286346A (ja) | ２，２−ビス（４′−アクリロイルオキシ−３′，５′−ジブロモフエニル）プロパンの製造法 | |
| US3046306A (en) | Process of preparing triiodinated analogs of thyronine | |
| JPS60258161A (ja) | システイン誘導体を製造する方法 | |
| SU730684A1 (ru) | Способ получени гидрохлорида бис /аминоизопропил/дисульфида | |
| JP2601708B2 (ja) | Ｎ―アルカノイルシステインの製造方法 | |
| JPH07267922A (ja) | カルボキシメチルシステインの製法 | |
| JPS6028827B2 (ja) | １−アミジノピペラジンの製造法 | |
| JPH0140031B2 (enrdf_load_stackoverflow) | ||
| JPS6158471B2 (enrdf_load_stackoverflow) | ||
| JPH0145469B2 (enrdf_load_stackoverflow) | ||
| JPH0129789B2 (enrdf_load_stackoverflow) | ||
| JPH04154756A (ja) | 界面活性剤の製造方法 | |
| JPH027317B2 (enrdf_load_stackoverflow) | ||
| JPS61130294A (ja) | α−ヒドロキシエチルホスフイン酸カルシウムの製造法 | |
| JPS6187688A (ja) | β−カルボキシエチルゲルマニウムセスキオキサイドの製造方法 |